In the News

First Venture Fund for Black-Owned Health Startups Launches with $55 Million

Health-tech startups have experienced immense success over the past two years. The need for remote care skyrocketed, and many digital health services found themselves outpacing initial growth projections as $29.1 billion was funneled into U.S. digital health startups in 2021 alone, according to Rock Health...

State of Minnesota Selects Truveris to Help Optimize Its Pharmacy Benefits Program

Program performance and pharmacy cost containment manager Truveris recently announced that the company has been selected as the exclusive oversight and procurement partner for the State of Minnesota. Together they will conduct a full reverse-auction process to guarantee the state’s pharmacy benefit needs are given...

Drugs by Drone: Good Idea?

With positive results from early tests, the drone industry is hopeful that lawmakers will increase their leniency in regulating drones. With this hope come questions about what should be considered a drone-deliverable item, specifically when it comes to controlled substances like pharmaceuticals. There are many angles...

Aetion Acquires Synthetic Data Trailblazer Replica Analytics

Regulatory-grade real-world evidence technology provider Aetion recently announced its acquisition of Replica Analytics. Replica Analytics is well known for creating synthetic health data through artificial intelligence programs. Replica will be able to help Aetion through its ability to preserve the utility of source data, thanks...

M2GEN Announces Collaboration with Microsoft to Advance Bioinformatics Solutions for Oncology

Bioinformatics company M2GEN announced a partnership with Microsoft in a move to improve and expand its data-driven solutions for research, discovery, and development of oncology therapies. The collaboration will combine M2GEN’s clinico-genomics database with Microsoft’s healthcare technologies to expand the possibilities of future cancer therapeutics. High-quality...

Be The Match BioTherapies® and Vineti collaborate to develop innovative, integrated supply chain management solutions for cell and gene therapies

Be The Match BioTherapies® and Vineti announced a collaboration to create streamlined solutions that alleviate supply chain management difficulties related to cell and gene therapies. The collaboration is non-exclusive and is expected to unite the industry’s top workflow programs: Vineti’s Personalized Therapy Management® platform and...